Cynata OTC Stock Price History Breakdown

CYYNF -  USA Stock  

USD 0.40  0.00  0.00%

Cynata OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings. As of today, the current price of Cynata Therapeutics is  0.40 , as last reported on the 7th of December, with the highest price reaching  0.40  and the lowest price hitting  0.40  during the day.
Cynata Therapeutics appears to be extremely dangerous, given 3 months investment horizon. Cynata Therapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had 0.17% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-four technical indicators for Cynata Therapeutics, which you can use to evaluate the future volatility of the firm. Please makes use of Cynata Therapeutics' mean deviation of 0.5944, and Risk Adjusted Performance of 0.1526 to double-check if our risk estimates are consistent with your expectations.

Cynata O TC Stock Price History 

 
Refresh

Cynata Therapeutics December 7, 2021 OTC Stock Price Synopsis

Cynata Therapeutics Price Rate Of Daily Change 1.00 
When benchmark price declines in a down market, there may be an uptick in Cynata Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Cynata Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Cynata Stock and then apply it to test your longer-term investment strategies against Cynata.

Cynata Therapeutics OTC Stock Price History Chart

There are several ways to analyze Cynata Stock price data. The simplest method is using a basic Cynata candlestick price chart, which shows Cynata Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

90 Days Highest PriceOctober 27, 20210.4
90 Days Lowest PriceSeptember 13, 20210.33

Cynata OTC Stock Price History Data

The price series of Cynata Therapeutics for the period between Wed, Sep 8, 2021 and Tue, Dec 7, 2021 has a statistical range of 0.07 with a coefficient of variation of 7.4. The prices are distributed with arithmetic mean of 0.37. The median price for the last 90 days is 0.37.
OpenHighLowCloseVolume
12/07/2021 0.40  0.40  0.40  0.40  1.00 
12/06/2021 0.40  0.40  0.40  0.40  1.00 
12/03/2021 0.40  0.40  0.40  0.40  1.00 
12/02/2021 0.40  0.40  0.40  0.40  1.00 
12/01/2021 0.40  0.40  0.40  0.40  1.00 
11/30/2021 0.40  0.40  0.40  0.40  1.00 
11/29/2021 0.40  0.40  0.40  0.40  1.00 
11/26/2021 0.40  0.40  0.40  0.40  1.00 
11/24/2021 0.40  0.40  0.40  0.40  1.00 
11/23/2021 0.40  0.40  0.40  0.40  1.00 
11/22/2021 0.40  0.40  0.40  0.40  1.00 
11/19/2021 0.40  0.40  0.40  0.40  1.00 
11/18/2021 0.40  0.40  0.40  0.40  1.00 
11/17/2021 0.40  0.40  0.40  0.40  1.00 
11/16/2021 0.40  0.40  0.40  0.40  1.00 
11/15/2021 0.40  0.40  0.40  0.40  1.00 
11/12/2021 0.40  0.40  0.40  0.40  1.00 
11/11/2021 0.40  0.40  0.40  0.40  1.00 
11/10/2021 0.40  0.40  0.40  0.40  1.00 
11/09/2021 0.40  0.40  0.40  0.40  1.00 
11/08/2021 0.40  0.40  0.40  0.40  1.00 
11/05/2021 0.40  0.40  0.40  0.40  1.00 
11/04/2021 0.40  0.40  0.40  0.40  1.00 
11/03/2021 0.40  0.40  0.40  0.40  1.00 
11/02/2021 0.40  0.40  0.40  0.40  1.00 
11/01/2021 0.40  0.40  0.40  0.40  1.00 
10/29/2021 0.40  0.40  0.40  0.40  1.00 
10/28/2021 0.40  0.40  0.40  0.40  1.00 
10/27/2021 0.40  0.40  0.40  0.40  1,200 
10/26/2021 0.37  0.37  0.37  0.37  1.00 
10/25/2021 0.37  0.37  0.37  0.37  1.00 
10/22/2021 0.37  0.37  0.37  0.37  1.00 
10/21/2021 0.37  0.37  0.37  0.37  1.00 
10/20/2021 0.37  0.37  0.37  0.37  1.00 
10/19/2021 0.37  0.37  0.37  0.37  1.00 
10/18/2021 0.37  0.37  0.37  0.37  1.00 
10/15/2021 0.37  0.37  0.37  0.37  1.00 
10/14/2021 0.37  0.37  0.37  0.37  1.00 
10/13/2021 0.37  0.37  0.37  0.37  1.00 
10/12/2021 0.37  0.37  0.37  0.37  1.00 
10/11/2021 0.37  0.37  0.37  0.37  1.00 
10/08/2021 0.37  0.37  0.37  0.37  1.00 
10/07/2021 0.37  0.37  0.37  0.37  1.00 
10/06/2021 0.37  0.37  0.37  0.37  1.00 
10/05/2021 0.37  0.37  0.37  0.37  1.00 
10/04/2021 0.37  0.37  0.37  0.37  1.00 
10/01/2021 0.37  0.37  0.37  0.37  1.00 
09/30/2021 0.37  0.37  0.37  0.37  1.00 
09/29/2021 0.37  0.37  0.37  0.37  1.00 
09/28/2021 0.37  0.37  0.37  0.37  1.00 
09/27/2021 0.37  0.37  0.37  0.37  1.00 
09/24/2021 0.37  0.37  0.37  0.37  100.00 
09/23/2021 0.33  0.33  0.33  0.33  1.00 
09/22/2021 0.33  0.33  0.33  0.33  1.00 
09/21/2021 0.33  0.33  0.33  0.33  1.00 
09/20/2021 0.33  0.33  0.33  0.33  1.00 
09/17/2021 0.33  0.33  0.33  0.33  1.00 
09/16/2021 0.33  0.33  0.33  0.33  1.00 
09/15/2021 0.33  0.33  0.33  0.33  1.00 
09/14/2021 0.33  0.33  0.33  0.33  1.00 
09/13/2021 0.33  0.33  0.33  0.33  1.00 

About Cynata Therapeutics OTC Stock history

Cynata Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cynata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cynata Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cynata Therapeutics historical stock prices may prove useful in developing a viable investing in Cynata Therapeutics
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. Cynata Therapeutics Limited was founded in 2011 and is based in Cremorne, Australia. Cynata Therapeutics is traded on OTC Exchange in the United States.

Cynata Therapeutics OTC Stock Technical Analysis

Cynata Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cynata Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cynata Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Cynata Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cynata stock's direction in advance. Along with the technical and fundamental analysis of Cynata OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cynata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Continue to Trending Equities. Note that the Cynata Therapeutics information on this page should be used as a complementary analysis to other Cynata Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Cynata OTC Stock analysis

When running Cynata Therapeutics price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Is Cynata Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cynata Therapeutics. If investors know Cynata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cynata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cynata Therapeutics is measured differently than its book value, which is the value of Cynata that is recorded on the company's balance sheet. Investors also form their own opinion of Cynata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cynata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cynata Therapeutics' market value can be influenced by many factors that don't directly affect Cynata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cynata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cynata Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cynata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.